0001209191-21-062781.txt : 20211103
0001209191-21-062781.hdr.sgml : 20211103
20211103182020
ACCESSION NUMBER: 0001209191-21-062781
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211102
FILED AS OF DATE: 20211103
DATE AS OF CHANGE: 20211103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUNT DOUGLAS M
CENTRAL INDEX KEY: 0001727172
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35703
FILM NUMBER: 211377026
MAIL ADDRESS:
STREET 1: C/O PUMA BIOTECHNOLOGY,INC.
STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PUMA BIOTECHNOLOGY, INC.
CENTRAL INDEX KEY: 0001401667
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770683487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
BUSINESS PHONE: (424) 248-6500
MAIL ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATIVE ACQUISITIONS CORP
DATE OF NAME CHANGE: 20070601
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-02
0
0001401667
PUMA BIOTECHNOLOGY, INC.
PBYI
0001727172
HUNT DOUGLAS M
C/O PUMA BIOTECHNOLOGY, INC.
10880 WILSHIRE BOULEVARD, SUITE 2150
LOS ANGELES
CA
90024
0
1
0
0
See Remarks
Common Stock
2021-11-02
4
S
0
427
5.641
D
65231
D
The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
/s/ Douglas M. Hunt
2021-11-03